SCHEMBL314127

SCHEMBL314127

O=C(O)CC[n+]1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCHE P06276 7/20 0.48
ACHE P22303 6/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5315062 0.97 BCHE (0.46) BCHEACHE
SCHEMBL170298 0.85 BCHE (0.56) BCHEACHE
Betaine SCHEMBL3179196 0.84 TSHR (0.52) BCHEACHE
SCHEMBL4471140 0.83 BCHE (0.61) BCHEACHE
Iodide SCHEMBL9575683 0.83 BCHE (0.54) BCHEACHE
Hydrochloric Acid SCHEMBL9575972 0.83 BCHE (0.54) BCHEACHE
SCHEMBL5533799 0.81 BCHE (0.65) BCHEACHE
SCHEMBL5538412 0.81 BCHE (0.65) BCHEACHE
SCHEMBL5536162 0.81 BCHE (0.65) BCHEACHE
SCHEMBL5538030 0.81 BCHE (0.65) BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107710462-B Electrochemical hydrogen storage electrode and battery 巴斯夫公司 2022-08-02 CN claimed
EP-3292578-B1 ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS BASF CORP (US) 2021-02-24 EP claimed
EP-3275039-A1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF Corporation (US) 2018-01-31 EP claimed
EP-3218955-A1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF Corporation (US) 2017-09-20 EP claimed
WO-2004005407-A2 TETRA-AZAPENTAMETHINE AND USE THEREOF FOR DYEING KERATINOUS FIBERS L'OREAL (FR) 2004-01-15 WO claimed
EP-1282602-A1 PROPANOIC ACID DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS Pharmacia Italia S.p.A. (IT) 2003-02-12 EP claimed
WO-2001087840-A1 PROPANOIC ACID DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS PHARMACIA ITALIA S.P.A. (IT) 2001-11-22 WO claimed
US-11832610-B2 Rheological modifiers for spray drift control in agrochemical emulsions DOW GLOBAL TECHNOLOGIES LLC (US) 2023-12-05 US disclosed
CN-107710462-B Electrochemical hydrogen storage electrode and battery 巴斯夫公司 2022-08-02 CN disclosed
EP-3292578-A1 ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS BASF Corporation (US) 2018-03-14 EP disclosed
EP-3275039-A1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF Corporation (US) 2018-01-31 EP disclosed
WO-2017172290-A1 SILICON-BASED SOLID ELECTROLYTE FOR RECHARGEABLE BATTERY BASF CORPORATION (US) 2017-10-05 WO disclosed
EP-3218955-A1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF Corporation (US) 2017-09-20 EP disclosed
EP-1814854-A1 CATIONIC CERAMIDES, AND ANALOGS THEREOF, AND THEIR USE FOR PREVENTING OR TREATING CANCER MUSC Foundation For Research Development (US) 2007-08-08 EP disclosed
WO-2006050264-A1 CATIONIC CERAMIDES, AND ANALOGS THEREOF, AND THEIR USE FOR PREVENTING OR TREATING CANCER MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2006-05-11 WO disclosed
WO-2004005407-A2 TETRA-AZAPENTAMETHINE AND USE THEREOF FOR DYEING KERATINOUS FIBERS L'OREAL (FR) 2004-01-15 WO disclosed
EP-1282602-A1 PROPANOIC ACID DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS Pharmacia Italia S.p.A. (IT) 2003-02-12 EP disclosed
WO-2001087840-A1 PROPANOIC ACID DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS PHARMACIA ITALIA S.P.A. (IT) 2001-11-22 WO disclosed
US-4105665-A MONOMETHINE DYESTUFFS BAYER AKTIENGESELLSCHAFT (DE) 1978-08-08 US disclosed
US-4018796-A FIBERS BAYER AKTIENGESELLSCHAFT (DT) 1977-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832610-B2 Rheological modifiers for spray drift control in agrochemical emulsions PLD1, PLD2, SRMS BCHE 2663/4885ACHE 1523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.